Aptevo Therapeutics Inc. Ttl Fee Amt
Aptevo Therapeutics Inc. (APVO) had Ttl Fee Amt of $2.48 thousand as of 2026-08-21, per its S-1 filed 2026-08-21.
Financial Statements › Notes
ffd:TtlFeeAmt · last filed 2026-08-21
- 2026-08-21: Ttl Fee Amt $2.48K.
- 2026-07-24: Ttl Fee Amt $9.00.
| Period end | Ttl Fee Amt |
|---|---|
| 2026-08-21 | $2.48K S-1 · filed 2026-08-21 |
| 2026-07-24 | $9.00 S-8 · filed 2026-07-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Onconetix, Inc. (ONCO) | United States | $0.004B | |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| HCW Biologics Inc. (HCWB) | United States | $0.004B | -6.15 |
| REVELATION BIOSCIENCES, INC. (REVB) | United States | $0.004B | |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B |